You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Obstructive HCM (oHCM)

Showing 1 - 25 of 5,284
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obstructive Hypertrophic Cardiomyopathy Trial in Boston, Kansas City, Omaha

Not yet recruiting
  • Obstructive Hypertrophic Cardiomyopathy
    • (no location specified)
    Aug 3, 2022

    Mavacamten in Korean Symptomatic Obstructive Hypertrophic

    Not yet recruiting
    • Obstructive Hypertrophic Cardiomyopathy
    • Seoul, Korea, Republic of
      Bristol-Myers Squibb YH
    Nov 23, 2023

    Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM

    Not yet recruiting
    • Obstructive Hypertrophic Cardiomyopathy
    • Charlottesville, Virginia
      University of Virginia
    Aug 28, 2023

    Obstructive Hypertrophic Cardiomyopathy Trial in China (Aficamten)

    Not yet recruiting
    • Obstructive Hypertrophic Cardiomyopathy
    • Beijing, China
    • +9 more
    Oct 31, 2023

    Obstructive Hypertrophic Cardiomyopathy Trial in Beijing (Mavacamten, Placebo)

    Recruiting
    • Obstructive Hypertrophic Cardiomyopathy
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jan 17, 2022

    Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial (Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match

    Not yet recruiting
    • Obstructive Hypertrophic Cardiomyopathy (oHCM)
    • Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg)
    • +3 more
    • (no location specified)
    Mar 2, 2023

    Hypertrophic Cardiomyopathy Trial in San Francisco (Moderate Intensity Exercise Program)

    Recruiting
    • Hypertrophic Cardiomyopathy
    • Moderate Intensity Exercise Program
    • San Francisco, California
      University of California - San Francisco
    Apr 5, 2023

    Patients' Long-Term Survival of Obstructive Hypertrophic

    Completed
    • Cardiomyopathy
    • Obstructive Hypertrophic Cardiomyopathy
      • Bethesda, Maryland
        National Heart, Lung and Blood Institute (NHLBI)
      May 27, 2022

      Obstructive Hypertrophic Cardiomyopathy Trial in Milan (pace maker implant guided by acute hemodynamic testing)

      Recruiting
      • Obstructive Hypertrophic Cardiomyopathy
      • pace maker implant guided by acute hemodynamic testing
      • Milan, Italy
        Istituto Auxologico Italiano
      Mar 6, 2023

      Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial in Worldwide (CK-3773274 (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match

      Recruiting
      • Obstructive Hypertrophic Cardiomyopathy (oHCM)
      • CK-3773274 (5 mg, 10 mg, 15 mg and 20 mg)
      • Placebo to match CK-3773274
      • Anchorage, Alaska
      • +31 more
      Aug 9, 2022

      Hypertrophic Cardiomyopathy (HCM) Trial in Worldwide (CK-3773274 (5 - 15 mg), CK-3773274 (10 - 30 mg), Placebo for CK-3773274)

      Recruiting
      • Hypertrophic Cardiomyopathy (HCM)
      • CK-3773274 (5 - 15 mg)
      • +2 more
      • Los Angeles, California
      • +21 more
      Mar 4, 2022

      Functional Capacity and Quality of Life Following Septal

      Recruiting
      • Hypertrophic Cardiomyopathy
        • Cleveland, Ohio
          Cleveland Clinic
        May 3, 2022

        Hypertrophic Cardiomyopathy, Hypertrophic Obstructive Cardiomyopathy, Familial Hypertrophic Cardiomyopathy Trial in Canada

        Enrolling by invitation
        • Hypertrophic Cardiomyopathy
        • +3 more
          • Calgary, Alberta, Canada
          • +10 more
          Oct 17, 2022

          Symptomatic Hypertrophic Cardiomyopathy (HCM) Trial in Italy, Spain, United States (CK-3773274 (5 - 20 mg))

          Enrolling by invitation
          • Symptomatic Hypertrophic Cardiomyopathy (HCM)
          • CK-3773274 (5 - 20 mg)
          • Los Angeles, California
          • +18 more
          Jan 31, 2023

          Hypertrophic Cardiomyopathy, Obstructive Hypertrophic Cardiomyopathy, Non-obstructive Hypertrophic Cardiomyopathy Trial in

          Active, not recruiting
          • Hypertrophic Cardiomyopathy
          • +2 more
          • Scottsdale, Arizona
          • +68 more
          Sep 20, 2022

          Hypertrophic Cardiomyopathy Trial in United States (mavacamten)

          Active, not recruiting
          • Hypertrophic Cardiomyopathy
          • Scottsdale, Arizona
          • +3 more
          Jun 10, 2022

          Obstructive Hypertrophic Cardiomyopathy Trial in Worldwide (mavacamten, Placebo)

          Completed
          Has Results
          • Obstructive Hypertrophic Cardiomyopathy
          • Scottsdale, Arizona
          • +70 more
          Sep 7, 2021

          HCM - Hypertrophic Non-Obstructive Cardiomyopathy Trial in Milan (Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die

          Completed
          • HCM - Hypertrophic Non-Obstructive Cardiomyopathy
          • Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die
          • Milan, Italy
            IRCCS Ospedale San Raffaele
          Dec 9, 2020

          Cardiomyopathy, Hypertrophic Obstructive Trial in Chuo-Ku (Mavacamten)

          Recruiting
          • Cardiomyopathy, Hypertrophic Obstructive
          • Uwajima, Ehime, Japan
          • +18 more
          Jan 20, 2023

          Non-obstructive Hypertrophic Cardiomyopathy Trial in United Kingdom, United States (IMB-1018972, Placebo)

          Recruiting
          • Non-obstructive Hypertrophic Cardiomyopathy
          • La Jolla, California
          • +13 more
          Oct 11, 2022

          Cardiomyopathy, Hypertrophic Trial in Worldwide (Mavacamten, Placebo)

          Not yet recruiting
          • Cardiomyopathy, Hypertrophic
          • West Hollywood, California
          • +9 more
          Oct 27, 2023

          Hypertrophic Cardiomyopathy Trial in Aswan

          Recruiting
          • Hypertrophic Cardiomyopathy
            • Aswan, Egypt
              Aswan Heart Centre - Magdi Yacoub Heart Foundation
            May 23, 2023

            Cardiomyopathy, Hypertrophic Trial in Bologna, Alicante/alacant (MYK-224)

            Not yet recruiting
            • Cardiomyopathy, Hypertrophic
            • Bologna, BO, Italy
            • +1 more
            Sep 23, 2022

            Hypertrophic Cardiomyopathy Trial in Madrid ("Symplicity Spyral" multi-electrode renal denervation catheter and "Symplicity G3"

            Recruiting
            • Hypertrophic Cardiomyopathy
            • "Symplicity Spyral" multi-electrode renal denervation catheter and "Symplicity G3" generator (Renal Denervation System)
            • Madrid, Spain
              Hospital Universitario 12 de Octubre
            Nov 26, 2022

            Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy Trial in Anchorage, Portland (Aficamten, Placebo)

            Recruiting
            • Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
            • Anchorage, Alaska
            • +1 more
            Oct 12, 2023